Samsung Electronics grew its operating profit nineteen-fold and the stock fell 7%. That single fact tells you everything about where this market is.
Wall Street’s one-day chip rebound evaporated on Tuesday as the semiconductor sell-off resumed with force. The Nasdaq Composite dropped 1.16% to 25,818.69, the S&P 500 slid 0.45% to 7,503.85, and the Dow — which touched a fresh all-time intraday high in early trading — reversed to close down 0.25% at 52,925.15. The Nasdaq 100 fell 1.77% on the very day SpaceX made its long-awaited debut in the index.
The VanEck Semiconductor ETF (SMH) plunged 4.5%. Applied Materials cratered nearly 10% intraday, Lam Research, KLA, Western Digital, and Intel each lost around 8% at the worst, AMD and Micron slid 7% before paring losses, and even Nvidia and Broadcom gave back roughly 2%. Adding to the pressure, Reuters reported that China’s DeepSeek is developing its own AI chip — another data point in the accelerating trend of AI companies designing around Nvidia and, by extension, around the entire merchant chip complex.
And yet, most S&P 500 constituents finished higher. Healthcare, energy, and communication services rallied. Johnson & Johnson and Verizon gained more than 3%; Coca-Cola, Procter & Gamble, and McDonald’s each rose over 2.5%. The rotation that has defined the past three weeks is not slowing down — it is accelerating.
Index Performance
Rates, Dollar, Commodities
Samsung: A 19-Fold Profit Surge Meets an Impossible Bar
Samsung’s preliminary Q2 results, released before the Korean market opened, were objectively historic. Revenue jumped 129% year-over-year to 171 trillion won, and operating profit soared roughly nineteen-fold to 89.4 trillion won (approximately $58.4 billion) — comfortably above the 84.2 trillion won consensus and a record for the company.
The stock fell 7% anyway, dragging the KOSPI down 4.9% and setting the tone for the global session. After a cumulative gain of up to 158% over the past eighteen months, the memory rally had already priced in perfection — and when perfection arrived, there was no one left to buy it.
Adam Crisafulli of Vital Knowledge captured the market’s dilemma precisely: “Q2 earnings results are likely to be quite robust on an absolute basis… but unlike with the Q1 season, expectations are presently very bullish (and the SPX is ~1K points higher than it was heading into the Q1 releases), which means the bar is quite elevated.”
That is the defining risk for the next six weeks. Micron already demonstrated it in late June — a monster beat followed by profit-taking. Samsung has now confirmed the pattern at even greater scale. When Nvidia, Meta, Microsoft, and Alphabet report later this month, beating estimates may no longer be enough; they will need to beat the whisper numbers layered on top of the estimates. The attention now shifts to SK Hynix, which prices its blockbuster Nasdaq IPO — a roughly $28 billion raise, one of the largest foreign listings in history — this Friday.
Oil Spikes as Iran Attacks a Tanker and Washington Pulls the Waiver
The session’s second headwind came from the Strait of Hormuz, where the fragile US-Iran peace framework showed its deepest cracks yet. Iran attacked a Qatari oil tanker near the strait, reigniting the maritime security fears that had only recently begun to fade as daily vessel traffic recovered.
Washington’s response was swift and consequential: the US Treasury revoked the sanctions waiver permitting Iranian oil sales — the 60-day license that had been the centerpiece of the June negotiating framework. Oil prices surged more than 5%, with Brent climbing above $76 per barrel and WTI topping $72. The jump in crude pushed bond yields higher, adding rate pressure to a tech sector already under valuation stress.
The escalation transforms the geopolitical calculus. What had been a de-escalation story supporting lower inflation and a patient Fed is now, at minimum, paused — and Thursday’s session would bring further deterioration.
SpaceX Joins the Nasdaq 100 — and Falls 6.8%
SpaceX officially entered the Nasdaq 100 before Tuesday’s open, setting a record for the fastest index inclusion in Nasdaq history — just 15 trading days after its June 12 debut. The inclusion triggered an estimated $4.3–6 billion in passive buying from index-tracking funds like QQQ.
It didn’t matter. The stock fell 6.83%, closing below its $150 opening print from IPO day, though still above the $135 offer price.
The decline came despite a wave of bullish analyst coverage as the post-IPO quiet period expired. Goldman Sachs, Morgan Stanley, J.P. Morgan, UBS, and Deutsche Bank all initiated with buy-equivalent ratings, with Raymond James staking out the most aggressive target on the Street at $800. MoffettNathanson stood alone with a neutral rating and a $131 target.
The skew deserves scrutiny. Nearly every firm issuing a bullish rating served as an underwriter on the IPO — institutions that collected fees on the offering and stand to earn more on future block trades as additional lock-up tranches are released. Research independence rules exist, but the structural incentives lean one direction, and quiet-period initiations from underwriting syndicates have historically skewed positive across virtually every major listing.
The market, for its part, is looking past the price targets and staring at the calendar: the first major lock-up expirations begin in August, potentially releasing a wave of insider and early-investor supply into a stock that has already fallen roughly 35% from its post-IPO peak. Index inclusion provides a mechanical bid, but it is a one-time event — lock-up supply is a recurring overhang.
Healthcare’s Quiet Bull Market
While technology absorbed the headlines, healthcare quietly extended one of the strongest sector runs of the summer. The day’s most dramatic single-stock story came from Vertex Pharmaceuticals, which announced a $10 billion acquisition of Crinetics Pharmaceuticals — sending the target soaring 98.8% while Vertex slipped 2%.
The deal underscores a broader dynamic: with AI valuations stretched and capital rotating out of semiconductors, healthcare offers what the market suddenly craves — defensive earnings, reasonable multiples, and now a resurgent M&A cycle. Johnson & Johnson’s 3% gain led the Dow, and the sector’s leadership over the past several sessions has been the clearest expression of the rotation trade.
The Magnificent Seven split down the middle: Meta, Amazon, Nvidia, Microsoft, and Alphabet advanced, while Tesla and Apple declined — Apple giving back a portion of its recent CXMT-driven rally.
Bottom Line
Tuesday delivered the cleanest demonstration yet of this market’s central tension. Samsung posted one of the great quarterly profit surges in corporate history and was punished for it — not because the results were bad, but because the market had already spent eighteen months paying for them in advance. The same dynamic hangs over every AI-linked name reporting this earnings season.
Meanwhile, the rotation beneath the surface continues to strengthen. Most stocks rose on a day the indices fell. Healthcare is breaking out. Defensives are leading the Dow. The market isn’t losing faith in the economy — it is repricing a single crowded trade while the other ten sectors quietly absorb the flows.
The wild card is once again geopolitical. With Iran attacking tankers and Washington revoking the oil waiver, the Hormuz de-escalation that underpinned June’s inflation optimism is unraveling. Oil above $76 changes the Fed math, and Wednesday’s FOMC minutes suddenly matter a great deal more than they did a day ago.
Leave a Reply